Healthcare

ResMed (ASX:RMD) to acquire MEDIFOX DAN in US$1.0B deal
June 15, 2022 03:25 PM AEST| By Sonal GoyalMedical device manufacturing company, ResMed Inc (ASX:RMD), has shared on Wednesday, that it will acquire MEDIFOX DAN for US$1.0 billion, under a definitive agreement. MEDIFOX DAN is a leader in out-of-hospital software solutions providers. ResMed.....

Pro Medicus (ASX:PME) inks two contract renewals worth AU$47M
June 14, 2022 01:24 PM AEST| By Sonal GoyalHighlights Pro Medicus has signed a renewal contract with Sutter Health for another seven years. A renewal contract is also inked with Wellspan Health for further five years. The share price of Pro Medicus has gained by over 650% in last 5 yea.....

Healthcare value stocks from ASX All Ordinaries: HLS, MVF, SHL, ANN
June 13, 2022 12:07 AM AEST| By Aditi SarkarHighlights Value stocks trade at a lower price corresponding to their fundamentals A high dividend yield and low P/B P/E ratios are common features of value stocks Healius reported a 100% increment in underlying unaudited EBITDA YTD to May 202.....

Pro Medicus signs US$28M contract with Allina Health; how are shares faring?
June 02, 2022 10:54 AM AEST| By AshishHighlights Pro Medicus signed a 7-year contract with a Minneapolis-based firm Allina Health. The deal with Alline Health is worth AU$28 million. The deal is expected to provide a unified diagnostic imaging platform across the network...

Recent updates from ASX healthcare stocks DXB and GLH
June 01, 2022 04:01 PM AEST| By Aditi SarkarHighlights Dimerix recruits the first subject for its DMX-200 phase 3 trial in patients with FSGS kidney disease. FSGS has a huge market opportunity as in the US alone, end stage renal failure amounted to an estimated cost of US$55 billion per .....

Mesoblast (ASX:MSB) posts US$23.1M third-quarter loss; how are shares faring?
June 01, 2022 11:14 AM AEST| By AshishHighlights Mesoblast’s loss after tax for the third quarter FY2022 was US$21.3 million. Total revenue rose 5% from the comparative quarter last year to US$2 million. Despite the loss, Mesoblast’s share price was trading a...

CSL, RHC, SHL: 3 ASX health care stocks on investors’ watchlist
May 31, 2022 02:20 PM AEST| By Aditi SarkarHighlights CSL has the largest market capitalisation (AU$131.32 billion) in the ASX health care space as of 31 May 2022 In 2020/21, CSL invested US$1,001 million in R&D activities Sonic reported revenue growth of 7% and net profit growth o.....

A look at 2 ASX-listed dental care stocks: SDI, PSQ
May 31, 2022 11:54 AM AEST| By Aditi SarkarHighlights Private dental clinics cater to more than 85% of dental care in Australia. Dental care stock SDI, which registered record 1H sales, expects new product releases and continued increases in market share to underpin growth momentum. CO.....

RAC, CTE, ADO: ASX health stocks with massive returns in past 3 years
May 28, 2022 12:45 AM AEST| By Aditi SarkarMultibaggers are lucrative stocks that provide returns several times higher than their initial investment value. To be more specific, if a stock price rises by double, it's called a double bagger, while if the price grows multiple times, it's calle.....

From REG to ICR: Latest updates from ASX-listed aged care stocks
May 26, 2022 07:37 PM AEST| By Aditi SarkarHighlights The Australian government provides funding to a range of aged care homes Regis Healthcare provides care for over 7,200 people throughout Australia Swift Networks has secured a new agreement worth AU$1.5 million with Hubify Limited .....

Volpara Health (ASX:VHT) exceeds revenue guidance in FY22
May 26, 2022 12:13 PM AEST| By Sonal GoyalHighlights Volpara marked 32% increase in revenue from customer contracts to NZ$26.1 million. Volpara delivered gross profit margin of over 91% in FY22. Volpara recorded 45% surge in the cash receipts. Health care technology provider, Vol.....

ALT and CDX: Why these ASX healthcare stocks were in news today
May 18, 2022 05:55 PM AEST| By Aditi SarkarHighlights The S&P/ASX 200 Health Care (AXHJ) is up today with a gain of 0.235% Shares of ALT ended Wednesday with an upsurge of 50% following the approval of European and Indian patents CardieX's CONNEQT Companion app gets an MDDS classif...

WFL, OSL, AVE: Three ASX healthcare stocks with over 20% QTD returns
May 17, 2022 10:52 AM AEST| By Aditi SarkarHighlights The Australian stock market closed on a higher note on Monday The benchmark of the ASX healthcare sector, S&P/ASX 200 Health Care, is up by 2.30% on a QTD basis WFL reported quarter-on-quarter cash receipts growth of 312% T.....

CSL’s (ASX: CSL) Vifor Pharma acquisition se to get delayed, shares fall
May 12, 2022 03:27 PM AEST| By Sukriti NairHighlights CSL Limited share price drops about 1.69% by afternoon today (12 May, 1:PM AEST). CSL has warned of a delay in the Vifor pharma acquisition. CSL shares also track the broader market and healthcare sector downtrend. Shares of th.....

Beamtree (ASX:BMT) signs US$7M contract with Ampath; shares surge
May 10, 2022 01:23 PM AEST| By RitwikaHighlights Beamtree has signed a five-year deal with Ampath for the implementation of its RippleDown software. The total value of the contract is AU$9.7 million. Backed by the announcement, the share price of Beamtree has gained mo.....

PME, MDR, CSL: A look at three ASX healthcare growth stocks
May 08, 2022 12:25 AM AEST| By Aditi SarkarHighlights Growth stocks are shares of the company estimated to increase sales and earnings faster than the market These stocks are likely to provide good price appreciation in the future Growth stocks also serve as a good hedge against inflat...

XPON subsidiary Wondaris expands reach by teaming up with Google CMU
May 06, 2022 05:43 PM AEST| By Aditi SarkarHighlights XPN’s Wondaris platform has teamed up with Google’s CMU program The partnership will allow clients to upload high-value audiences safely through easy and clickable workflow Customers will now be able to deliver marketing.....

3D Printing: A great approach in healthcare innovations
May 05, 2022 07:30 PM AEST| By Aditi SarkarHighlights 3D printing technology is used in developing new surgical cuttings, patient-specific replicas of bones, organs and blood vessels The innovative technology has created long-lasting and better-fitting implants 3D printers that can rep...

Clinuvel (ASX:CUV) shares upbeat results from afamelanotide drug trial
May 04, 2022 01:05 PM AEST| By Aditi SarkarHighlights: CUV has received encouraging outcomes from the first clinical study assessing afamelanotide as a treatment for a life-threatening brain injury. In the clinical study, five out of six patients receiving afamelanotide recovered well i.....

IPD, MX1 & MDR: Three ASX health tech stocks with strong revenue in 3Q
May 04, 2022 11:27 AM AEST| By Aditi SarkarHighlights ImpediMed saw record results for total revenue and SOZO SaaS revenue in Q3. Micro-X achieved good growth in Mobile DR unit sales with expanded network, distributors and inventory on hand. MedAdvisor reported a 96.1% YoY surge in ope.....

Advertise your brand on Kalkine Media